Bioprocess Challenges in Purification of Therapeutic Protein Charge Variants

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Bioprocess Challenges in Purification of Therapeutic Protein Charge Variants

Cited by 4 publications

References 73 publications

Highly purified charge variants of a proposed biosimilar to Omalizumab: impact on in vitro potency and stability under thermal stress

Highly purified charge variants of a proposed biosimilar to Omalizumab: impact on in vitro potency and stability under thermal stress

Study on the S239D/I332E mutation effect on the kinetics of Fc–Fc receptor binding through transition complex theory

Utilization and prospect of purification technologies in natural proteins, peptides and recombinant proteins

Contact Info

Product

Resources

About